Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +11.21% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +11.62% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Publication of a circular and notice of general meeting
- The Biotech Growth Trust PLC - Annual Financial Report
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust Plc - Transaction in Own Shares
- The Biotech Growth Trust Plc - Net Asset Value(s)
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 30 April 2024
- The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation
- The Biotech Growth Trust Plc - Total Voting Rights
More ▼
Key statistics
On Thursday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 980.00, -6.49% below its 52-week high of 1,048.00, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 33.09m |
---|---|
Market cap | 323.92m GBP |
Total assets | 359.57m GBP |
Total expense ratio | 1.18% |
High | 982.00 |
Low | 974.00 |
Previous close | 979.00 |
Average volume | 96.58k |
---|---|
YTD Change | +9.62% |
Beta | 0.6081 |
Diluted NAV (est) | 1,066.38 |
Diluted NAV (last pub) | 1,057.49 |
Premium/Discount | -8.10% |
Net Gearing | +2.40% |
Data delayed at least 20 minutes, as of Jun 13 2024 16:35 BST.
More ▼